Showing results (271-280 of 560) with videos related to

Sort By:
Pageof 56
Life Sciences|August 26, 1999
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528D Shire, B Calandra, M Bouaboula, et al.
The British Journal of Surgery|October 31, 2001
Long-term effects of stapled haemorrhoidectomy on internal anal function and sensitivityD F Altomare, M Rinaldi, P L Sallustio, et al.
The Journal of Cardiovascular Surgery|March 5, 2005
Solitary cardiac metastasis from a clear cell carcinoma of the kidney. A case report and review of the literatureG F Zattera, A Alloni, A M D'Armini, et al.
British Journal of Cancer|January 1, 1997
Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodiesM Mottolese, I Venturo, M Rinaldi, et al.
Public Health Nutrition|July 5, 2021
Taxing sugar-sweetened beverages as a policy to reduce overweight and obesity in countries of different income classifications: a systematic reviewAlexander Itria, Stéfani S Borges, Ana Elisa M Rinaldi, et al.
Progress in Lipid Research|November 3, 2025
N-Acylethanolamines in cancer: mechanisms and therapeutic potential of lipid regulators of tumor behaviorM F Nanì, M M Rinaldi, M Miraglia, et al.
ACS Applied Nano Materials|April 12, 2024
Post-synthesis Oxidation of Superparamagnetic Iron Oxide Nanoparticles to Enhance Magnetic Particle Imaging PerformanceAmbar C Velazquez-Albino, Aniela Nozka, Andrii Melnyk, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trialC Gridelli, S Cigolari, C Gallo, et al.
Current Medicinal Chemistry|June 6, 2012
The role of EGFR tyrosine kinase inhibitors in the first-line treatment of advanced non small cell lung cancer patients harboring EGFR mutationA Sgambato, F Casaluce, P Maione, et al.
Anticancer Research|May 16, 2000
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literatureC Gridelli, L Frontini, E Barletta, et al.
Pageof 56